0
0
12/22/22 at 8:15am
Organization
European Pharmaceutical Review
30 words
0
Comments
Stem cell transplants may delay disability longer than other medications in patients with active secondary progressive multiple sclerosis.
You are the first to view
https://www.europeanpharmaceuticalreview.com/news/177879/stem-cell-transplants-may-slow-disability-progression-in-ms/
Create an account
or login to join the discussion